Bank of the West’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
CI
Bank of the West's XBI Position: Q3 2019 in Review
Bank of the West sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2019, closing a stake of 8,679 shares — an estimated $761K sold.
Bank of the West first reported a position in XBI in Q3 2018 and held it in 4 quarters. The position peaked at $858K in Q3 2018. 406 funds tracked by Wall St. Rank hold XBI as of Q3 2019.
- Bank of the West reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2019 after selling out during the quarter.
- Bank of the West sold 8,679 State Street SPDR S&P Biotech ETF shares in Q3 2019, an estimated $761K.
- Bank of the West first reported a position in State Street SPDR S&P Biotech ETF in Q3 2018 and held it in 4 quarters.
- Bank of the West's State Street SPDR S&P Biotech ETF position peaked at $858K in Q3 2018.
- 406 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2019.
Based on Bank of the West's 13F filing for Q3 2019, filed 28 Oct 2019.